Welcome Panthers Fans!
Our proven technology reduces the cost of pharmaceutical process development and manufacturing, and our companions with a significant competitive advantage as they respond to increasing market demands for lower cost pharmaceuticals. .. Codexis announces licensing agreement with Teva Pharmaceutical Industries Codexis, Inc. Today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, utilizing a proprietary Codexis biocatalyst. Teva, the largest generic drug producer in the world, is a respected producer of this generic product. The merchandise is one of the largest – offering generic prescription drugs in the usa. Related StoriesANI acquires 22 previously marketed generic drug products for $25 million from Teva PharmaceuticalsANI acquires approved ANDA for Flecainide Acetate tablets USPUnder the agreement, Teva would be using the Codexis procedure for key process measures in the produce of the product, assuming technical milestones are met.The Kaiser Daily Wellness Policy Report is published for Kaisernetwork.org, a free of charge program of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Firm and Kaiser Family Base. All rights reserved.
CDC releases Global Health Strategy 2012-2015 The Centers for Disease Control and Prevention recently released its Global Health Strategy 2012-2015 , which ‘outlines how CDC will leverage its primary strengths to advance 4 overarching global wellness goals: improving medical and well-being of people around the world, improving capabilities for preparing and giving an answer to infectious diseases and emerging wellness threats, building country public health capability and maximizing organizational capacity,’ based on the strategy website .